|
CapitalBio Corporation
massarray methylation profiling and data analysis Massarray Methylation Profiling And Data Analysis, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/massarray methylation profiling and data analysis/product/CapitalBio Corporation Average 90 stars, based on 1 article reviews
massarray methylation profiling and data analysis - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
SPSS Inc
massarray dna methylation analysis ![]() Massarray Dna Methylation Analysis, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/massarray dna methylation analysis/product/SPSS Inc Average 90 stars, based on 1 article reviews
massarray dna methylation analysis - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Sequenom
sequenom massarray methylation ![]() Sequenom Massarray Methylation, supplied by Sequenom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sequenom massarray methylation/product/Sequenom Average 86 stars, based on 1 article reviews
sequenom massarray methylation - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Epigenetics
Article Title: HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC
doi: 10.4161/15592294.2014.969625
Figure Lengend Snippet: The primers used to amplify the HLA-DRB1 and DQB1 translational start codon for Massarray DNA methylation analysis
Article Snippet: The primers used to amplify the HLA-DRB1 and DQB1 translational start codon for
Techniques: DNA Methylation Assay, Amplification
Journal: Multiple sclerosis and related disorders
Article Title: Ultra-high field spinal cord MRI in multiple sclerosis: Where are we standing? A literature review.
doi: 10.1016/j.msard.2021.103436
Figure Lengend Snippet: Fig. 4. Cd interfered with the DNA methylation of Oct4 and Nanog of mouse ES cells into ovarian GCs. A and E represented the methylation status of CpG islands on DNA templates in the promoter regions of both factors was evaluated using the Sequenom MassARRAY Methylation. B and F: DNA methylation rate of CpG locus in the promoter region of different sites of both factors. C–K represented the degree of DNA methylation on different fragments of the factors in maps and DNA methylation rate in the promoter region in each fragment and groups. Data are presented as the mean ± SD, *P < 0.05 compared with the IA group.
Article Snippet: The DNA methylation levels of the upstream promoter regions of the four markers were detected by the
Techniques: DNA Methylation Assay, Methylation
Journal: Multiple sclerosis and related disorders
Article Title: Ultra-high field spinal cord MRI in multiple sclerosis: Where are we standing? A literature review.
doi: 10.1016/j.msard.2021.103436
Figure Lengend Snippet: Fig. 5. Cd interfered with the DNA methylation of Amhr2 and Sox2 of mouse ES cells into ovarian GCs. A and E represented the methylation status of CpG islands on DNA templates in the promoter regions of both factors was evaluated using the Sequenom MassARRAY Methylation. B and F: DNA methylation rate of CpG locus in the promoter region of different sites of both factors. C-K represented the degree of DNA methylation on different fragments of the factors in maps and DNA methylation rate in the promoter region in each fragment and groups. Data are presented as the mean ± SD, *P < 0.05 compared with the IA group.
Article Snippet: The DNA methylation levels of the upstream promoter regions of the four markers were detected by the
Techniques: DNA Methylation Assay, Methylation